Log In
Print this Print this

AuriPro (formerly OTO-201)

  Manage Alerts
Collapse Summary General Information
Company Otonomy Inc.
DescriptionSustained-release gel formulation of ciprofloxacin
Molecular Target DNA gyrase
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentRegistration
Standard IndicationOtitis media
Indication DetailsIntraoperative treatment of middle ear effusion in pediatric patients requiring tympanostomy tube placement surgery; Treat acute otitis media (AOM); Treat acute otitis media with tympanostomy tubes; Treat otitis media in pediatric patients undergoing tympanostomy tube replacement surgery; Treat recurrent or persistent otitis media
Regulatory Designation


 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today